Cure My Disease

Don't miss your cure!

 Log in / Sign up

Targeted attack: new combo therapies tested for Tough-to-Treat lung cancer

NCT ID NCT05170204

Ongoing Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

Summary

This study is testing personalized drug combinations for people with a specific type of advanced lung cancer (Stage III NSCLC) that cannot be removed by surgery. It aims to see if adding new targeted drugs to standard treatment can better control the cancer and prevent it from spreading. Participants are grouped based on specific genetic markers found in their tumor to receive the treatment most likely to help them.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, 05505, South Korea

  • Asst Grande Ospedale Metropolitano Niguarda

    Milan, Lombardy, 20162, Italy

  • Centre Francois Baclesse

    Caen, 14000, France

  • Centre Leon Berard

    Lyon, 69008, France

  • Chonnam National University Hwasun Hospital

    Jeollanam-do, 58128, South Korea

  • Christie Hospital Nhs Trust

    Manchester, M2O 4BX, United Kingdom

  • Dolno?l?skie Centrum Chorób P?uc we Wroc?awiu

    Wroc?aw, 53-439, Poland

  • Faculty of Med. Siriraj Hosp.

    Bangkok, 10700, Thailand

  • Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo

    Bogota, D.C., 110131, Colombia

  • Helios Klinikum Emil von Behring GmbH

    Berlin, 14165, Germany

  • Hillman Cancer Center

    Pittsburgh, Pennsylvania, 15232, United States

  • Hopital Nord

    Marseille, 13915, France

  • Hospital Civil de Guadalajara Fray Antonio Alcalde

    Guadalajara, Jalisco, 44280, Mexico

  • Hospital Universitario San Ignacio

    Bogotá, 000472, Colombia

  • Hospital de Cancer de Barretos

    Barretos, São Paulo, 14784-400, Brazil

  • Hunan Cancer Hospital

    Changsha, 410013, China

  • IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola

    Meldola, Emilia-Romagna, 47014, Italy

  • Instituto do Cancer do Estado de Sao Paulo - ICESP

    São Paulo, São Paulo, 01246-000, Brazil

  • Juntendo University Hospital

    Tokyo, 113-8431, Japan

  • Kagoshima University Hospital

    Kagoshima, 890-8520, Japan

  • Karolinska Universitetssjukhuset, Solna

    Stockholm, 171 76, Sweden

  • Kindai University Hospital

    Ōsaka-sayama, 589-8511, Japan

  • Kobe City Medical Center General Hospital

    Hyōgo, 650-0047, Japan

  • Korea University Guro Hospital

    Seoul, 08308, South Korea

  • Kumamoto University Hospital

    Kumamoto, 860-8556, Japan

  • Kurume University Hospital

    Fukuoka, 830-0011, Japan

  • Kyungpook National University Chilgok Hospital

    Daegu, 41404, South Korea

  • NHO Kyushu Cancer Center

    Fukuoka, 811-1395, Japan

  • National Cancer Centre

    Singapore, 168583, Singapore

  • Northwest Cancer Specialists, P.C.

    Tigard, Oregon, 97223, United States

  • Oncology Unit, Faculty of Medicine, Vajira Hospital

    Dusit, 10300, Thailand

  • One Clinical Research

    Nedlands, Western Australia, 6009, Australia

  • Peter MacCallum Cancer Centre

    Melbourne, Victoria, 3000, Australia

  • Pusan National University Yangsan Hospital

    Gyeongsangnam-do, 50612, South Korea

  • Rajavithi Hospital

    Bangkok, 10400, Thailand

  • RedSalud Vitacura

    Santiago, Chile

  • Sahlgrenska University Hospital

    Gothenburg, 413 45, Sweden

  • Seoul National University Bundang Hospital

    Seongnam-si, 13605, South Korea

  • Shandong Cancer Hospital

    Jinan, 250117, China

  • Shanghai Pulmonary Hospital

    Shanghai, 200433, China

  • Songklanagarind Hospital

    Songkhla, 90110, Thailand

  • Taichung Veterans General Hospital

    Taichung, 40705, Taiwan

  • The Cancer Institute Hospital of JFCR

    Tokyo, 135-8550, Japan

  • UZ Gent

    Ghent, 9000, Belgium

  • Xinqiao Hospital of Third Military Medical University

    Chongqing, 400037, China

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER